Literature DB >> 937835

Lipids found in pulmonary lavage of patients with alveolar proteinosis and in rabbit lung lamellar organelles.

S Sahu, R P DiAugustine, W S Lynn.   

Abstract

Lipids from the insoluble material obtained by pulmonary lavage of 6 patients with alveolar proteinosis and from lamellar organelles of normal rabbit lungs were isolated and characterized. In both types of samples, dipalmitoylphosphatidylcholine was the predominant lipid. Phosphatidylethanolamine, phosphatidylglycerol, lysophosphatidylglycerol, and 2 glycolipids, GM3 and GL1 were also present in both types of preparations. Sphingomyelin, lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidyl-N, N-dimethylethanolamine, phosphatidylserine, and lyso(bis)phosphatidic acid were found in the sedimented lavage material from humans but were not detected in lamellar organelles from rabbits. Significant quantities of neutral lipids were present in the lavage material, but only trace amounts, mainly as cholesterol and triglycerides, were detected in lamellar organelles. Phosphatidylcholine and the 2 glycolipids contained mostly saturated fatty acids and essentially no polyunsaturated fatty acids. Sphingomyelin, lysophosphatidycholine, and phosphatidyl-N, N-dimethylethanolamine, found only in the lavage, were also highly saturated. In addition to the fact that several phospholipids found in the lavage were not present in lamellar organelles, another striking difference between the lipids from these 2 sources was that phosphatidylglycerol of lamellar organelles contained predominantly palmitic acid, whereas the phosphatidylglycerol obtained by lavage of humans contained large amounts of stearic and oleic acids.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 937835     DOI: 10.1164/arrd.1976.114.1.177

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  21 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Changes in pulmonary surfactant and phosphatidylcholine metabolism in rats exposed to chrysotile asbestos dust.

Authors:  T D Tetley; R J Richards; J L Harwood
Journal:  Biochem J       Date:  1977-09-15       Impact factor: 3.857

3.  Pulmonary alveolar proteinosis: determination of prostaglandins and leukotrienes in lavage fluid.

Authors:  F J Zijlstra; J E Vincent; B van den Berg; H C Hoogsteden; H J Neyens; J J van Dongen
Journal:  Lung       Date:  1987       Impact factor: 2.584

4.  Biochemical definition of human tracheobronchial mucus.

Authors:  P Roussel; P Degand; G Lamblin; A Laine; J J Lafitte
Journal:  Lung       Date:  1978       Impact factor: 2.584

5.  Surfactant apoprotein in nonmalignant pulmonary disorders.

Authors:  G Singh; S L Katyal
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

6.  A high-molecular-weight alveolar glycoprotein in human amniotic fluid.

Authors:  S C Sahu; W S Lynn
Journal:  Lung       Date:  1980       Impact factor: 2.584

7.  A high-molecular-weight alveolar glycoprotein in the cell-free culture medium of human fetal lung type II pneumocytes.

Authors:  S C Sahu; A K Tanswell; W S Lynn
Journal:  Lung       Date:  1980       Impact factor: 2.584

8.  Hyaluronic acid in the pulmonary secretions of patients with asthma.

Authors:  S Sahu; W S Lynn
Journal:  Biochem J       Date:  1978-08-01       Impact factor: 3.857

9.  Lipid composition of sputum from patients with asthma and patients with cystic fibrosis.

Authors:  S Sahu; W S Lynn
Journal:  Inflammation       Date:  1978-03       Impact factor: 4.092

10.  Hyaluronic acid in the pulmonary secretions of patients with alveolar proteinosis.

Authors:  S Sahu; W S Lynn
Journal:  Inflammation       Date:  1978-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.